LUTEtium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LUTEtium, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium [Phase 1, Phase 2]